Intensity Therapeutics (INTS) Q2 2025 Earnings

13MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.36
-0.31
-0.25
-0.2

Details

Expected EPS
-0.2
Actual EPS
-0.22
Surprise EPS
-0.02
Surprise Percent
+10%

Description

Intensity Therapeutics (INTS) has reported earnings of -0.22 per share for Q2 2025.

0 Comments

Share your thoughts